Natco Pharma is a prominent publicly traded Indian pharmaceutical company whose ownership is distributed among institutional investors, mutual funds, foreign portfolio investors, and public shareholders, alongside its founding promoter family. The promoter group is led heavily by V. C. Nannapaneni, who serves as the Chairman and Managing Director, working alongside other executive family members and senior professional management teams to guide the company's specialized oncology, complex generic development, and active pharmaceutical ingredient manufacturing strategies globally.